Schedule 13G ownership disclosure

Tango Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 87583X109

Event date: 2025-12-31

Filing-level shares
10,072,225.00
Percent of class
7.5%
  • Woodline Partners LP

    Shares: 10,072,225.00 · Class: 7.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-001066
Form type
SCHEDULE 13G/A
Filer
Tango Therapeutics, Inc.
CIK
CIK 1819133
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub